The establishment of polypeptide PSMA‐targeted chimeric antigen receptor‐engineered natural killer cells for castration‐resistant prostate cancer and the induction of ferroptosis‐related cell death-Reference-Cited by-同舟云学术

The establishment of polypeptide PSMA‐targeted chimeric antigen receptor‐engineered natural killer cells for castration‐resistant prostate cancer and the induction of ferroptosis‐related cell death

Published:2022-06-15 Issue:8 Volume:42 Page:768-783
ISSN:2523-3548
Container-title:Cancer Communications
language:en
Short-container-title:Cancer Communications

Author:

Wu Liyuan¹²,Liu Fei¹²,Yin Le³⁴,Wang Fangming¹²,Shi Hui³⁴,Zhao Qinxin¹²,Yang Feiya¹²,Chen Dong¹²,Dong Xiying⁵,Gu Yuchun³⁶⁴,Xing Nianzeng¹²⁷

Affiliation:

1. State Key Laboratory of Molecular Oncology National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Beijing 100021 P. R. China

2. Department of Urology National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Beijing 100021 P. R. China

3. Molecular Pharmacology Laboratory Institute of Molecular Medicine Peking University Beijing 100871 P. R. China

4. Research and Development Department Allife Medicine Inc. Beijing 100176 P. R. China

5. Peking Union Medical College Hospital Peking Union Medical College and Chinese Academy of Medical Sciences Beijing 100730 P. R. China

6. Translation Medicine Research Group Aston Medical School Aston University, Birmingham B4 7ET United Kingdom

7. Department of Urology, Shanxi Province Cancer Hospital/Shanxi Hospital Affiliated to Cancer Hospital Chinese Academy of Medical Sciences/Cancer Hospital Affiliated to Shanxi Medical University Taiyuan Shanxi 030013 P. R. China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cac2.12321

Reference39 articles.

1. Cancer incidence, mortality, and burden in China: a time‐trend analysis and comparison with the United States and United Kingdom based on the global epidemiological data released in 2020

2. Longitudinal trends in prostate cancer incidence, mortality, and survival of patients from two Shanghai city districts: a retrospective population-based cohort study, 2000–2009

3. Reciprocal Network between Cancer Stem‐Like Cells and Macrophages Facilitates the Progression and Androgen Deprivation Therapy Resistance of Prostate Cancer. Clinical Cancer Research.2018:clincanres.0461.2018.

4. Treating Patients with Metastatic Castration Resistant Prostate Cancer: A Comprehensive Review of Available Therapies

5. SEMA3A-mediated crosstalk between prostate cancer cells and tumor-associated macrophages promotes androgen deprivation therapy resistance

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Left out in the cold: Moving beyond hormonal therapy for the treatment of immunologically cold prostate cancer with CAR T cell immunotherapies;The Journal of Steroid Biochemistry and Molecular Biology;2024-10

2. CAR Macrophages: a promising novel immunotherapy for solid tumors and beyond;Biomarker Research;2024-08-23

3. Ferroptosis crosstalk in anti-tumor immunotherapy: molecular mechanisms, tumor microenvironment, application prospects;Apoptosis;2024-07-15

4. Regulation of ferroptosis by nanotechnology for enhanced cancer immunotherapy;Expert Opinion on Drug Delivery;2024-06-02

5. Ferroptosis in cancer: from molecular mechanisms to therapeutic strategies;Signal Transduction and Targeted Therapy;2024-03-08